StockData
LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc. (LFST) stock

LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30143% above fair value
$14.15−0.22 (-1.53%)

Close on Nov 12, 2026Market cap $5.41BP/E 74.5Yield –

LifeStance Health profit margin

Profit margin (net margin) is net income as a percentage of revenue.

LifeStance Health's profit margin for the twelve months ending Sep 30, 2026 was 4.3%. For fiscal 2025 it was 0.7%, against -4.6% the year before. The highest annual figure on record is 2.7% in fiscal 2019.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20250.7%+5.3
FY2024Dec 31, 2024-4.6%+13.1
FY2023Dec 31, 2023-17.6%+7.4
FY2022Dec 31, 2022-25.1%+20.9
FY2021Dec 31, 2021-46.0%−48.7
FY2019Dec 31, 20192.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 20264.9%+4.6
Q2 FY2026Jun 30, 20265.4%+6.5
Q1 FY2026Mar 31, 20263.5%+3.3
Q4 FY2025Dec 31, 20253.1%+5.2
Q3 FY2025Sep 30, 20250.3%+0.1
Q2 FY2025Jun 30, 2025-1.1%+6.4
Q1 FY2025Mar 31, 20250.2%+7.2
Q4 FY2024Dec 31, 2024-2.2%+13.8
Q3 FY2024Sep 30, 20240.2%+23.7
Q2 FY2024Jun 30, 2024-7.5%+10.1
Q1 FY2024Mar 31, 2024-7.0%+6.5
Q4 FY2023Dec 31, 2023-16.0%+4.3
Q3 FY2023Sep 30, 2023-23.4%−6.0
Q2 FY2023Jun 30, 2023-17.5%+15.3
Q1 FY2023Mar 31, 2023-13.6%+17.1
Q4 FY2022Dec 31, 2022-20.3%+36.5
Q3 FY2022Sep 30, 2022-17.4%+51.9
Q2 FY2022Jun 30, 2022-32.8%+10.8
Q1 FY2022Mar 31, 2022-30.7%−24.6
Q4 FY2021Dec 31, 2021-56.9%−53.6
Q3 FY2021Sep 30, 2021-69.3%−59.7
Q2 FY2021Jun 30, 2021-43.6%–
Q1 FY2021Mar 31, 2021-6.1%–
Q3 FY2020Sep 30, 2020-3.2%–
Q2 FY2020Jun 30, 2020-9.6%–

More LifeStance Health figures

See a number that looks wrong?